2025-04-06 - Analysis Report
## Chevron Corp (CVX) Stock Report

**0) Summary Statistics:**

Chevron Corp (CVX) is an American multinational energy corporation.  The provided data shows a cumulative return significantly lagging the S&P 500 (VOO) over the period analyzed.  Recent price action indicates a downward trend, and financial metrics present a mixed picture of profitability and growth.

**1) Performance Comparison:**

* **CVX Cumulative Return:** 31.15%
* **VOO (S&P 500) Cumulative Return:** 71.02%
* **Return Difference:** -39.9%
* **Relative Lag:** 36.0% (This means CVX's underperformance relative to VOO is at the 36th percentile of historical performance differences.)

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 34.0% | 5.4% | 5.0% | 0.1 | 161.5 |
| 2016-2018  | 23.0% | 62.6% | 6.0% | 0.3 | 145.8 |
| 2017-2019  | 6.0% | 62.6% | -23.0% | 0.8 | 168.0 |
| 2018-2020  | -36.0% | 62.6% | -65.0% | -0.6 | 124.4 |
| 2019-2021  | 13.0% | 59.0% | -61.0% | -0.9 | 181.9 |
| 2020-2022  | 85.0% | 74.9% | 64.0% | -1.1 | 288.3 |
| 2021-2023  | 65.0% | 74.9% | 37.0% | 1.1 | 249.0 |
| 2022-2024  | 4.0% | 74.9% | -11.0% | 0.4 | 252.2 |
| 2023-2025  | -55.0% | 73.5% | -57.0% | 0.8 | 252.3 |

The table shows significant volatility in CAGR and Alpha, indicating inconsistent outperformance relative to the market (Beta is also volatile).  High Maximum Drawdowns (MDD) highlight the risk associated with CVX.


**2) Recent Price Movement:**

* **Closing Price:** $143.28
* **Previous Close:** $156.12
* **Change:** -$8.22 (a significant daily drop)
* **5-Day Moving Average:** $160.33
* **20-Day Moving Average:** $161.07
* **60-Day Moving Average:** $156.55

The price is below all three moving averages, suggesting a bearish short-term trend.  The large daily price decrease warrants further investigation into the underlying causes.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4693 (High Risk)
* **RSI:** 30.11 (Oversold territory, potentially suggesting a bounce, but not confirming an uptrend)
* **PPO:** -1.11 (Negative, indicating bearish momentum)
* **20-Day Relative Divergence Change:** -2.9 (Short-term downward trend)
* **Expected Return:** -18.0% (Significant negative expected return relative to S&P 500 over the long term).  This needs clarification on the methodology for calculating this value.


The combination of high MRI, low RSI, negative PPO, and negative relative divergence points toward a bearish outlook. The substantial daily price drop (-8.22) suggests a potential market reaction to negative news, which requires further investigation.


**4) Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|----------------|
| 2024-11-07 | 2.49 | $48.93B       |
| 2024-08-07 | 2.43 | $49.57B       |
| 2024-05-02 | 2.99 | $46.58B       |
| 2023-11-02 | 3.48 | $51.92B       |
| 2024-11-07 | 3.48 | $51.92B       |

There seems to be a duplicate entry for 2024-11-07.  Excluding duplicates, EPS shows a downward trend in recent quarters, although revenue is relatively stable.  A further analysis of the reasons behind the declining EPS is needed.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue      | Profit Margin |
|---------|---------------|---------------|
| 2024-12-31 | $48.33B      | 27.34%        |
| 2024-09-30 | $48.93B      | 29.15%        |
| 2024-06-30 | $49.57B      | 29.66%        |
| 2024-03-31 | $46.58B      | 31.66%        |
| 2023-12-31 | $48.93B      | 29.02%        |

Revenue is relatively consistent, but profit margins show a slight downward trend.


**Capital and Profitability:**

| Quarter | Equity        | ROE           |
|---------|----------------|---------------|
| 2024-12-31 | $152.32B      | 2.13%         |
| 2024-09-30 | $156.20B      | 2.87%         |
| 2024-06-30 | $159.23B      | 2.78%         |
| 2024-03-31 | $160.62B      | 3.42%         |
| 2023-12-31 | $160.96B      | 1.40%         |

Equity is gradually decreasing, and ROE is volatile, suggesting some uncertainty regarding the company's profitability and capital efficiency.


**6) Overall Analysis:**

CVX has significantly underperformed the S&P 500 over the analyzed period. Recent price action and technical indicators suggest a bearish short-term outlook.  While revenue remains relatively stable, declining EPS and profit margins, combined with high risk indicators and a negative long-term expected return relative to the S&P 500, raise concerns. The significant daily price drop requires further investigation to determine the underlying causes.  A thorough analysis of the company's future prospects, competitive landscape, and any significant news events is crucial before making any investment decisions.  The provided data alone does not provide sufficient information to make a definitive recommendation.
